Envista Holdings Corp is expected to report second-quarter 2026 revenue of $716.5 million and adjusted earnings of $0.33 per share, while the stock currently trades at $27.31 against an average analyst price target of $29.43. The primary metric investors are monitoring is core sales growth, as shareholders look for evidence that momentum in high-margin dental segments can be sustained through the fiscal year.
Management previously established a full-year 2026 core revenue growth target of 2% to 4%, driven by strong demand for the Spark clear aligner line and premium implant systems. Investors are also watching for continued adjusted EBITDA margin expansion, which reached 14.8% in the previous quarter, signaling improved operational leverage from the Envista Business System.